| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |